Thalidomide in cancer
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference61 articles.
1. Thalidomide for resistant and relapsing myeloma;Alexanian;Semin Hematol,2000
2. Phase II evaluation of thalidomide in patients with metastatic breast cancer;Baidas;J Clin Oncol,2000
3. Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients;Barlogie;Blood,2001
4. Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia;Barosi;Br J Haematol,2001
5. Langerhans-cell histiocytosis in the adult: regressive parotid involvement following thalidomide therapy;Bensaid;Ann Dermatol Venereol,1992
Cited by 96 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients;Cancers;2024-06-28
2. A Novel Nanoemulsion Formula for an Improved Delivery of a Thalidomide Analogue to Triple-Negative Breast Cancer; Synthesis, Formulation, Characterization and Molecular Studies;International Journal of Nanomedicine;2023-03
3. Design, synthesis, anticancer evaluation, and in silico ADMET analysis of novel thalidomide analogs as promising immunomodulatory agents;RSC Advances;2023
4. Recent Advances in the Development of Thalidomide-Related Compounds as Anticancer Drugs;Current Medicinal Chemistry;2022-01
5. WaterMap and Molecular Dynamic Simulation-Guided Discovery of Potential PAK1 Inhibitors Using Repurposing Approaches;ACS Omega;2021-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3